NEWSLETTER
RSS
MOBILE
HELP
Nektar Therapeutics, Inc. (NKTR)
SHARE
Email Confirmation
OPEN
LAST
$
PREV CLOSE
CHANGE
VOLUME
Overview
News
People
Financials
Company Information
Overview
A biopharmaceutical company that develops and enables differentiated therapeutics with its PEGylation and pulmonary drug development technology platforms.
News Feeds
-
Nektar 3Q loss widens on revenue drop
AP
Nov 07 2008
-
Nektar says early test of cancer drug was positive
AP
Oct 24 2008
Press Releases
-
InSite Vision Names Louis Drapeau Interim CEO Nov-05-2008, 04:58PM EST
-
Nektar Therapeutics to Webcast R&D Day on November 12th Oct-27-2008, 08:30AM EDT
-
Beacon Equity Issues Technical Trade Alerts on Market Movers: AAPL, ICOG, NKTR, STSI, HA, AVGN Oct-23-2008, 09:00AM EDT
News From Around the Web
News
-
Nektar Therapeutics Q3 2008 Earnings Call Transcript
(SeekingAlpha)Nov 20 2008 -
Nektar 3Q loss widens on revenue drop (Boston Globe)Nov 07 2008
Employees
Number of Employees: 575
Revenue per Employee: $349,506
Top Executives
Tim Riley, Ph.D., Vice President, Divisional
John Nicholson, CFO/Senior VP
Nevan C. Elam, J.D., Senior VP, Divisional
Dr. Bharatt M. Chowrira, Ph.D., J.D., COO/Other Corporate Officer
Jillian B. Thomsen, Chief Accounting Officer/Vice President
Gil M. Labrucherie, J.D., General Counsel/Secretary/Senior VP
Dr. Randall W. Moreadith, M.D., Ph.D., Other Executive Officer/Senior VP, Divisional
Dr.John S. Patton, Ph.D., Founder/Director/Other Executive Officer
John "Jay" M. Sisco, Ph.D., Vice President, Divisional
Board of Directors
Irwin Lerner, Director
Robert B. Chess, Chairman of the Board/Director
Gil M. Labrucherie, J.D., General Counsel/Secretary/Senior VP
Financials
Quarterly
Annual
| Income Statement | 11/2008 | 08/2008 | 05/2008 | 02/2008 |
|---|---|---|---|---|
| Sales | -985 K. | -241 K. | 7.1 Mil. | 18.44 Mil. |
| Gross Operating Profit | 22.42 Mil. | 20.64 Mil. | 12.89 Mil. | 47.34 Mil. |
| Operating Income before D & A (EBITDA) | -27.99 Mil. | -27.44 Mil. | -36.19 Mil. | -5.97 Mil. |
| Total Income Before Interest Expenses (EBIT) | -32.77 Mil. | -29.16 Mil. | -36.57 Mil. | 44.08 Mil. |
| Total Net Income | -37.04 Mil. | -33.38 Mil. | -40.7 Mil. | 39.04 Mil. |
| Basic EPS, Total | -0.4 | -0.36 | -0.44 | 0.42 |
| Diluted EPS, Total | -0.4 | -0.36 | -0.44 | 0.42 |
| BALANCE STATEMENT | 11/2008 | 08/2008 | 05/2008 | 02/2008 |
|---|---|---|---|---|
| Cash and Equivalents | 63.71 Mil. | 31.83 Mil. | 36.68 Mil. | 76.29 Mil. |
| Total Assets | 410.29 Mil. | 410.13 Mil. | 443.52 Mil. | 523.28 Mil. |
| Total Liabilities | 48.52 Mil. | 58.76 Mil. | 57.64 Mil. | 98.09 Mil. |
| Total Capitalization | 423.63 Mil. | 458.7 Mil. | 490.76 Mil. | 529.44 Mil. |
| Cash Flow | 11/2008 | 08/2008 | 05/2008 | 02/2008 |
|---|---|---|---|---|
| Net Cash From Continuing Operations | -115.06 Mil. | -96.42 Mil. | -64.97 Mil. | 146.3 Mil. |
| Net Cash From Investing Activities | 104.22 Mil. | 52.89 Mil. | 25.38 Mil. | -32.66 Mil. |
| Net Cash From Financing Activities | -1.43 Mil. | -768 K. | -34.29 Mil. | -101.77 Mil. |
| Net Change in Cash & Cash Equivalents | -12.58 Mil. | -44.46 Mil. | -39.62 Mil. | 12.53 Mil. |
| Income Statement | 2008 | 2007 | 2006 | 2005 |
|---|---|---|---|---|
| Sales | 120.31 Mil. | 89.49 Mil. | 13.97 Mil. | 4.54 Mil. |
| Gross Operating Profit | 152.72 Mil. | 128.22 Mil. | 112.31 Mil. | 109.74 Mil. |
| Operating Income before D & A (EBITDA) | -57.19 Mil. | -99.48 Mil. | -83.2 Mil. | -54.76 Mil. |
| Total Income Before Interest Expenses (EBIT) | -12.81 Mil. | -133.68 Mil. | -171.16 Mil. | -76.3 Mil. |
| Total Net Income | -32.76 Mil. | -154.76 Mil. | -185.11 Mil. | -101.89 Mil. |
| Basic EPS, Total | -0.36 | -1.72 | -2.15 | -1.3 |
| Diluted EPS, Total | -0.36 | -1.72 | -2.15 | -1.3 |
| BALANCE STATEMENT | 2008 | 2007 | 2006 | 2005 |
|---|---|---|---|---|
| Cash and Equivalents | 76.29 Mil. | 63.76 Mil. | 261.27 Mil. | 104.41 Mil. |
| Total Assets | 523.28 Mil. | 535.04 Mil. | 519.84 Mil. | 454.54 Mil. |
| Total Liabilities | 98.09 Mil. | 165.31 Mil. | 69.6 Mil. | 55.65 Mil. |
| Total Capitalization | 529.44 Mil. | 542.06 Mil. | 744.46 Mil. | 641.29 Mil. |
| Cash Flow | 2008 | 2007 | 2006 | 2005 |
|---|---|---|---|---|
| Net Cash From Continuing Operations | 146.3 Mil. | -92.72 Mil. | -78 Mil. | -78.14 Mil. |
| Net Cash From Investing Activities | -32.66 Mil. | -116.88 Mil. | 32.4 Mil. | -88.91 Mil. |
| Net Cash From Financing Activities | -101.77 Mil. | 11.77 Mil. | 274.85 Mil. | 207.41 Mil. |
| Net Change in Cash & Cash Equivalents | 12.53 Mil. | -197.51 Mil. | 229.21 Mil. | 40.36 Mil. |
Related Companies by Market Cap
Company Name
Price
Change
Market Cap
968.78 Mil.
331.7 Mil.
326.67 Mil.
305.49 Mil.
Company Profile Change Request
The data provided in our company profiles comes from third party information providers.- To request a change please click here
Also in Portfolio.com
Most Read
Most Emailed
Recently Commented
TOP 5
(Daily)
A smart take on the top stories shaping the business world.
Executives & Careers
(Tuesdays)
A weekly guide to the personalities and ideas that are transforming the business world.
Inside Portfolio.com
(Wednesdays)
Our roundup of the week's best from Portfolio.com.
Culture & Lifestyle
(Fridays)
A weekly guide to the best ways to spend your time - and money.
In This Issue
(Monthly)
Be the first to know when the latest issue of Condé Nast Portfolio magazine is online.
RSS Most Read
Mobile